Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - ezetimibe; simvastatin - tablet - 10 mg/20 milligram(s) - simvastatin and ezetimibe

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - ezetimibe; simvastatin - tablet - 10 mg/40 milligram(s) - simvastatin and ezetimibe

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - ezetimibe; simvastatin - tablet - 10 mg/80 milligram(s) - simvastatin and ezetimibe

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - rosuvastatin calcium, quantity: 10.4 mg (equivalent: rosuvastatin, qty 10 mg) - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; lactose monohydrate; light magnesium oxide; crospovidone; titanium dioxide; hypromellose; triacetin; iron oxide red - primary hypercholesterolaemiapharmacor ezetimibe rosuvastatin composite pack is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:,? not appropriately controlled with rosuvastatin or ezetimibe alone; or,? already treated with rosuvastatin and ezetimibe,homozygous familial hypercholesterolaemia (hofh),pharmacor ezetimibe rosuvastatin composite pack is indicated for patients with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis).

Malta - English - Medicines Authority

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - ezetimibe - tablet - ezetimibe 10 mg - lipid modifying agents

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - simvastatin, quantity: 10 mg; ezetimibe, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; croscarmellose sodium; citric acid monohydrate; butylated hydroxyanisole; magnesium stearate; hypromellose; microcrystalline cellulose; propyl gallate; sodium lauryl sulfate - adults (?18 years),prevention of cardiovascular disease,ezetimibe and simvastatin tablets is indicated in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs) taking their maximum tolerated dose of simvastatin and in need of additional lowering of ldl-c in the expectation of a modest further reduction in the risk of cardiovascular events following at least one year of therapy.,primary hypercholesterolaemia,ezetimibe and simvastatin tablets is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate:,? patients not appropriately controlled with a statin or ezetimibe alone.,? patients already treated with a statin and ezetimibe.,homozygous familial hypercholesterolaemia (hofh),ezetimibe and simvastatin tablets is indicated in patients with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis).,children and ado

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ezetimibe; simvastatin - tablet - 10 mg/20 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ezetimibe; simvastatin - tablet - 10 mg/80 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ezetimibe; simvastatin - tablet - 10 mg/40 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - ezetimibe; simvastatin - tablet - 10 mg/10 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe